Home
  • About Diabetic
    Foot Causes
    • Diabetic Foot Causes
    • Diabetic Foot Symptoms
    • Diabetic Foot Complications
    • Diabetic Foot Treatment
    • Preventing Diabetic Foot
    • Educational Handbook
  • Selecting
    Fespixion
    • Development Process
    • Clinical Trials
    • Mechanism
    • Literature Review
    • Quality Certification
  • Starting
    Fespixion
    • Indications and Dosagen
    • Drug Safety
    • Package Insert
    • Usage Videos
  • Stories
    • Popular Articles
    • Popular Videos
  • About
    Oneness
    • Company Introduction
    • Core Values and Business Philosophy
    • Corporate Sustainable Responsibility
  • Contact Us
  • 繁
  • 简
  • EN

Popular Articles

2021-09-10
Medscape
Novel Diabetic Foot Ulcer Cream Shows Promise in Phase 3 Trial
2021-09-10
Medical Dialogues
Topical Application Of Novel Drug Improved Healing In Patients With Diabetic Fool Ulcers: JAMA
2021-09-08
2 minute medicine
Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing
2021-09-07
BioSpace
A novel macrophage-regulating new drug has shown promise in treating diabetic foot ulcers according to the latest issue of article published by the JAMA Network Open
2021-09-07
Podiatry Management
RE: Novel Macrophage-Regulating Drug-Effect on Wound Healing in Patients With DFUs
2021-09-03
Medpage Today
Topical Cream Effective Against Diabetic Foot Ulcers — Investigational compound regulates macrophages, is "active-healing alternative," researchers
  • ‹
  • 1
  • 2
  • ›
Home
icon Address:35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City, Taiwan (R.O.C.)
icon Phone:+886 (0)2-2703-1098
icon Fax:+886 (0)2-2703-1200
icon Facebook
icon Contact Us
icon Linkedln
Privacy Policy Copyright © Oneness Biotech Co., Ltd.. All Rights Reserved.